Hsp90-Cdc37-IN-3
CAT:
804-HY-144650-01
Size:
10 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No

Hsp90-Cdc37-IN-3
- CAS Number: 2361009-68-7
- UNSPSC Description: Hsp90-Cdc37-IN-3 (Compound 9) is a novel celastrol?imidazole derivative with anticancer activity. Hsp90-Cdc37-IN-3 inhibits Hsp90?Cdc37 by covalent-binding, and induces apoptosis[1].
- Target Antigen: Apoptosis; HSP
- Type: Reference compound
- Related Pathways: Apoptosis;Cell Cycle/DNA Damage;Metabolic Enzyme/Protease
- Applications: Cancer-programmed cell death
- Field of Research: Cancer
- Assay Protocol: https://www.medchemexpress.com/hsp90-cdc37-in-3.html
- Solubility: DMSO : 100 mg/mL (ultrasonic)
- Smiles: O=C1C(O)=C(C2=CC=C3[C@](C)([C@]4(CC[C@]3(C2=C1)C)C)CC[C@@]5([C@@]4([H])C[C@](C(OCCCN6C(Cl)=NC([N+]([O-])=O)=C6)=O)(CC5)C)C)C
- Molecular Weight: 638.19
- References & Citations: [1]Na Li, et al. Discovery of Novel Celastrol-Imidazole Derivatives with Anticancer Activity In Vitro and In Vivo. J Med Chem. 2022 Mar 24;65(6):4578-4589.
- Shipping Conditions: Room Temperature
- Clinical Information: No Development Reported